Generally very safe in culinary quantities. High-dose curcumin supplements may cause gastrointestinal upset. May interact with anticoagulants (warfarin), antidiabetic drugs, and acid-suppressing medications. Avoid very high doses during pregnancy and breastfeeding. Rarely causes allergic reactions.

Safety note^{[13, 14, 15]}Caution

Duke (2002) rates turmeric as +++ with clinical evidence (score 2) for anti-inflammatory activity, consistent with Commission E and WHO approvals. Curcumin is the primary bioactive compound with well-documented anti-inflammatory, antioxidant, anti-aggregant, and hepatoprotective effects. Duke notes Commission E approval for dyspeptic complaints. Dose: 1.5–3 g dried rhizome powder daily. A major pharmacological consideration is bioavailability: curcumin alone has low absorption, but combining with piperine (black pepper) increases bioavailability by up to 2000%. Contraindicated in bile duct obstruction; use with caution in gallstones and during pregnancy at medicinal doses (Duke, 2002).

References

REF-0791, REF-0792, REF-0793, REF-2164, REF-2165, REF-2166, REF-2167, REF-2168, REF-2169, REF-2170, REF-2171, REF-2172

References & Sources

Zeng, L., Yang, T., Yang, K., Yu, G. et al (2022) 'Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Frontiers in Immunology, 13, pp. 891822. doi:10.3389/fimmu.2022.891822 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.891822
Zeng, L., Yu, G., Hao, W., Yang, K. and Chen, H (2021) 'The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis', Bioscience Reports, 41(6), pp. BSR20210817. doi:10.1042/BSR20210817 Meta-analysis / review
https://doi.org/10.1042/BSR20210817
Marton, L.T., Pescinini-E-Salzedas, L.M., Camargo, M.E.C., Barbalho, S.M. et al (2021) 'The Effects of Curcumin on Diabetes Mellitus: A Systematic Review', Frontiers in Endocrinology, 12, pp. 669448. doi:10.3389/fendo.2021.669448 Meta-analysis / review
https://doi.org/10.3389/fendo.2021.669448
Kocaadam, B. and Sanlier, N (2017) 'Curcumin, an active component of turmeric (Curcuma longa), and its effects on health', Critical Reviews in Food Science and Nutrition, 57(13), pp. 2889-2895. doi:10.1080/10408398.2015.1077195 Meta-analysis / review
https://doi.org/10.1080/10408398.2015.1077195
Vaughn, A.R., Branum, A. and Sivamani, R.K (2016) 'Effects of turmeric (Curcuma longa) on skin health: a systematic review of the clinical evidence', Phytotherapy Research, 30(8), pp. 1243-1264. doi:10.1002/ptr.5640 Meta-analysis / review
https://doi.org/10.1002/ptr.5640
Soleimani, V., Sahebkar, A. and Hosseinzadeh, H (2018) 'Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review', Phytotherapy Research, 32(6), pp. 985-995. doi:10.1002/ptr.6054 Meta-analysis / review
https://doi.org/10.1002/ptr.6054
Zeng, L., Yang, T., Yang, K., Yu, G., Li, J., Xiang, W. and Chen, H (2022) 'Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: a systematic review and meta-analysis of 31 randomized controlled trials', Frontiers in Immunology, 13, pp. 896476. doi:10.3389/fimmu.2022.896476 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.896476
Razavi, B.M., Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2021) 'A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents', Phytotherapy Research, 35(12), pp. 6489-6513. doi:10.1002/ptr.7224 Meta-analysis / review
https://doi.org/10.1002/ptr.7224
Memarzia, A., Khazdair, M.R., Behrouz, S., Gholamnezhad, Z., Jafarnezhad, M., Saadat, S. and Boskabady, M.H (2021) 'Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review', BioFactors, 47(3), pp. 311-350. doi:10.1002/biof.1716 Meta-analysis / review
https://doi.org/10.1002/biof.1716
Jurenka, J.S (2009) 'Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research', Alternative Medicine Review, 14(2), pp. 141-153. Meta-analysis / review
Find this source
Hosseini, A. and Hosseinzadeh, H (2018) 'Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: a review', Biomedicine & Pharmacotherapy, 99, pp. 411-421. doi:10.1016/j.biopha.2018.01.072 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2018.01.072
Araujo, C.C. and Leon, L.L (2001) 'Biological activities of Curcuma longa L', Memorias do Instituto Oswaldo Cruz, 96(5), pp. 723-728. doi:10.1590/s0074-02762001000500026 Meta-analysis / review
https://doi.org/10.1590/s0074-02762001000500026
Aggarwal, B.B. and Harikumar, K.B (2009) 'Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases', 41(1), pp. 40--59. Traditional / reference
Find this source
Shoba, G. et al (1998) 'Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers', 64(4), pp. 353--356. Clinical study
Find this source
WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
Find this source

Generated June 22, 2026 from omniasana.bio